Ligand Pharmaceuticals
LGND
₹9,337
Share price
-1.15%
Change (1 day)
53.77%
Change (1 year)
Earnings for Ligand Pharmaceuticals (LGND)
Earnings in 2024 (TTM): ₹0.37 Billion
According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are ₹0.16 Billion. a decrease over its 2023 earnings that were of ₹5.55 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Ligand Pharmaceuticals from 1994 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | ₹0.47 B | -91.37% |
| 2023 | ₹5.55 B | -7.59% |
| 2022 | ₹6.00 B | 4% |
| 2021 | ₹5.77 B | 296.42% |
| 2020 | ₹1.45 B | -97.97% |
| 2019 | ₹71.86 B | 275.62% |
| 2018 | ₹19.13 B | 237.48% |
| 2017 | ₹5.66 B | 49.05% |
| 2016 | ₹3.80 B | 55.41% |
| 2015 | ₹2.44 B | 36.87% |
| 2014 | ₹1.78 B | 29.59% |
| 2013 | ₹1.37 B | 1309.35% |
| 2012 | ₹97.9 M | -43.97% |
| 2011 | ₹0.17 B | -113.19% |
| 2010 | -₹1.33 Billion | 59.86% |
| 2009 | -₹0.83 Billion | -61.33% |
| 2008 | -₹2.15 Billion | -58.75% |
| 2007 | -₹5.2 Billion | 20.52% |
| 2006 | -₹4.32 Billion | 81.27% |
| 2005 | -₹2.38 Billion | |
| 2003 | -₹1.66 Billion | -20.6% |
| 2002 | -₹2.09 Billion | 4.38% |
| 2001 | -₹2 Billion | -48.83% |
| 2000 | -₹3.91 Billion | -19.74% |
| 1999 | -₹4.87 Billion | -19.06% |
| 1998 | -₹6.01 Billion | 126.71% |
| 1997 | -₹2.66 Billion | -5.83% |
| 1996 | -₹2.82 Billion | 136.23% |
| 1995 | -₹1.2 Billion | -33.97% |
| 1994 | -₹1.81 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | ₹397.92 B | 82,930.08% | 🇺🇸 USA |
 | -₹5.35 Billion | -1,214.77% | 🇺🇸 USA |
 | ₹379.40 B | 79,066.64% | 🇬🇧 UK |
 | ₹1.830 T | 381,939.27% | 🇺🇸 USA |
 | ₹959.45 B | 200,098.16% | 🇺🇸 USA |
 | ₹1.094 T | 228,334.52% | 🇺🇸 USA |
 | -₹723.42 Billion | -151,045.78% | 🇺🇸 USA |
 | -₹51.2 Billion | -10,782.76% | 🇺🇸 USA |
 | ₹1.505 T | 314,113.66% | 🇺🇸 USA |